Elevated levels of three proteins were detected in the urine of patients with early-stage pancreatic cancer.
Results of blood tests to detect DNA shed from tumors were found to predict cancer recurrence far earlier than standard imaging methods.
Revised guidelines for thyroid cancer testing now both incorporate personalized medicine and the latest tests.
Study shows potential for noninvasive tumor detection for head and neck cancer.
Incorporating maternal plasma cell-free DNA into routine noninvasive prenatal testing (NIPT) could aid early detection of maternal tumors, according to study data.
Most frequently biopsied incidental malignancies were seen on the head and neck.
New research indicates that magnetic resonance imaging (MRI) might have a role in early detection for those at high genetic risk of pancreatic cancer.
Certain conditions make it harder to reliably detect tumors, and regions with locally-endemic infectious lung diseases pose an added hurdle for lung cancer detection.
A new screening technique, MR fusion guided prostate biopsy, holds promise for increased prostate cancer detection.
By 2024, the number of Americans with a history of cancer is expected to grow to 19 million.
Researchers have developed a breathalyzer that can detect lung cancer and assess whether it is early or advanced, according to findings presented at the 2014 annual meeting of the American Society of Clinical Oncology.
Panel distinguishes early cancer from healthy controls, chronic pancreatitis, benign cysts
Panels of microRNA expression can potentially distinguish pancreatic cancer from healthy controls, according to a study.
New findings that run counter to federal recommendations indicate that women should be encouraged to initiate regular mammographic screening before age 50 years.
Free screenings for head and neck cancer can increase early detection and provide an opportunity to educate people about risk factors. But who is most likely to attend these screenings, and what do attendees know about head and neck cancer?
Most deaths from breast cancer occur in younger women who do not receive regular mammograms, according to a new study. The study indicates that regular screening before age 50 years should be encouraged.
A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal, according to a new study.
Carbohydrate antigen 125 (CA125) testing, already used to predict ovarian cancer recurrence, has now shown strong results as a screening technique for early-stage disease when combined with transvaginal ultrasound.
Algorithm is used to estimate risk of ovarian cancer in postmenopausal women and demonstrates high specificity.
A considerable proportion of children with melanoma do not present with conventional ABCDE detection criteria.
A telephone outreach intervention delivered by Medicaid managed care organization (MMCO) staff can increase rates of colorectal cancer (CRC) screening among women overdue for screening, according to a study.
Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.
Researchers have identified a biomarker for colorectal cancer that can be obtained from a small amount of serum DNA in less than 1 mL of blood and that is highly sensitive and specific for the disease.
Digital chest tomosynthesis holds promise as a first-line tool for lung cancer screening, according to the baseline results of a single-arm, observational study.
Next generation genomic analysis has determined that some of the more aggressive prostate cancers have similar genetic origins, according to a recent publication
Digital direct radiography is significantly more effective than computed radiography at detecting breast cancer, according to a new study.
Exposure to Agent Orange has been linked to lethal forms of prostate cancer among US veterans by a new analysis.
Digital breast tomosynthesis may be more accurate than mammography but with greater radiation exposure, additional study comparing the detection methods would be beneficial.
Patients at higher or lower risk for having their cancer recur elsewhere in the body more than 5 years after diagnosis can be differentiated by a gene expression test. The test measures the expression levels of 58 genes in estrogen receptor-positive breast cancers. These research results were presented at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
- Breakthrough supportive care: Overcoming cancer anorexia/cachexia
- Study uses dog sledding to demonstrate benefits of adapted physical activities for children with cancer
- What are immune checkpoints and how do they work?
- Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: A meta-analysis of Phase III randomized controlled trials
- Patients with advanced cancer prefer open, effective communication
- Religiousness and spirituality have a significant impact on cancer patients' overall health and outcomes
- Dietary intervention primes triple-negative breast cancer cells for targeted therapy
- Lung cancer patients who stop smoking live longer
- Review examines strategies for hospital room surface cleanliness
- Appropriate use of tomosynthesis mammography
- Antibiotic use was associated with increased risk for some cancers
- ADT impacts mood of patients with prostate cancer, as perceived by partners
- Varubi approved for nausea and vomiting associated with cancer chemo
- Higher frequency of BRCA mutations observed in black women
- Genetic test helps identify risk for more aggressive disease, improving myeloma treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|